Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Westleaf Inc. WSLFF

Healthcare Drug Manufacturers - Major Cannabis
Westleaf is a Canadian cannabis company focused on cannabis brands, extraction and production of derivatives, wholly owned retail, as well as cannabis cultivation. The Company’s extraction and processing facility, The Plant, will produce high quality and consistent cannabis derivatives and consumables, both for Westleaf’s in-house brands as well as white label products. Westleaf’s retail concept, Prairie Records, leverages the instinctual tie between recreational cannabis and music.


GREY:WSLFF - Post by User

Westleaf Inc. > Eight Capital: Buy rating and $0.70 target for Westleaf Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(4)
•••
Comment by stealthcton Jan 12, 2020 10:11am
81 Views
Post# 30543715

RE:RE:Eight Capital: Buy rating and $0.70 target for Westleaf Inc.

RE:RE:Eight Capital: Buy rating and $0.70 target for Westleaf Inc.
Eight Capital downgraded from $1.10 to $0.70.

If you want an extractor with no debt, huge issued and pending patent portfolio and revenue of 40 - 50M for 2020, Nextleaf Solutions is the best bet.

There buy rating is at 1.75/each.

Likely doing to get huge coverage soon from a bigger analyst firm. Nextleaf Solutions will easily fly.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities